Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of 12-months of Denosumab on Bone Density, Quality and Strength in Prevalent Kidney Transplant Recipients

NCT03960554 is registered in ClinicalTrials.gov with Thomas Nickolas, MD MS as lead sponsor.

NCT NCT03960554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of 12-months of Denosumab on Bone Density, Quality and Strength in Prevalent Kidney Transplant Recipients
Lead sponsor
Thomas Nickolas, MD MS
Phase
Phase 2
Overall status
Terminated
Start date
January 16, 2020
Completion date
December 2, 2021
Enrollment
8 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant; complications, osteoporosis, renal osteodystrophy